Stellar Biotechnologies, Inc. 4
4 · Stellar Biotechnologies, Inc. · Filed Mar 27, 2017
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Award
Share Option (Right to Buy)
2017-03-23+2,500→ 2,500 totalExercise: $1.67Exp: 2024-03-23→ Common Shares (2,500 underlying)
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 23, 2018 and as to the remaining one-third on September 23, 2018.